|
Mumbai,6th
December,2006
The latest
report by Bharat Book Bureau on the Indian Pharmaceutical
sector, titled “India Pharmaceutical Report” gives a
thorough overview of the Indian pharmaceutical sector.
The report
mentions that India ranked eleventh in the global
pharmaceutical market, with a global market share of around
1.41% in the year 2005. In the same year, the pharmaceutical
industry in India was estimated to be worth USD 8.8 billion,
with a growth rate of 7.2%.
The Indian
pharmaceutical industry is known for supplying and providing
affordable generic versions of patented drugs for major
illnesses to some of the world’s poorest countries. The
Indian pharmaceutical industry relied on ‘reverse
engineering’, i.e., product copying, through which major
profits were made.
But in the
recent years, the pharmaceutical manufacturers in India have
realized the importance of research to penetrate
the regulated markets in the USA and the European
Union, in order to survive the global market.
The report
deals with the in-depth analysis of the Indian
pharmaceutical industry, along with updated statistics for
the first and second quarters, including tables and graphs
and expert views from the analysts. It also includes
information on the leading players in the market, like Cipla,
Ranbaxy Laboratories, Dr.Reddy’s Laboratories, and Wockhardt
etc.
For more
information visit:
http://www.bharatbook.com/detail.asp?id=26467 |
